Home LiteratureArticle Details
PMID: 3003584 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.

Nature ·Vol. 319 ·No. 6054 ·1986-00-00 ·Pages 555-9

Rosen CA, Sodroski JG, Goh WC, Dayton AI, Lippke J, Haseltine WA

Abstract

The level of synthesis of viral proteins and heterologous proteins under the control of long terminal repeat sequences of human T-lymphotropic virus type III (HTLV-III or LAV) increases dramatically in cells that constitutively express the HTLV-III trans-activator protein. Increased levels of protein synthesis occur without a comparable increase in the levels of corresponding messenger RNA. We propose that post-transcriptional events mediated by the HTLV-III trans-activator protein account for positive regulation of HTLV-III gene products in infected cells.

MeSH Terms
DNA Restriction Enzymes Deltaretrovirus/genetics,growth & development Humans Plasmids RNA Processing, Post-Transcriptional RNA, Messenger/analysis,genetics RNA, Viral/analysis Repetitive Sequences, Nucleic Acid Transfection Viral Proteins/biosynthesis,genetics Virus Activation
Chemicals
RNA, Messenger RNA, Viral Viral Proteins DNA Restriction Enzymes
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Rosen C A
Sodroski J G
Goh W C
Dayton A I
Lippke J
Haseltine W A
Article Info
Journal
Nature
Abbr.
Nature
ISSN
0028-0836
Published
1986-00-00
Pages
555-9
Language
English
Region
England
NLM ID
0410462
Subset
IM
Grants
NCI NIH HHS · CA07580 · United States
NCI NIH HHS · CA40658 · United States
Databases
GENBANK
K03455
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com